News

Celebrating Modivcare's Maine Driver of the Year Honor

Celebrating Modivcare's Maine Driver of the Year Honor

Payson Priola: A Beacon of Excellence in Non-Emergency Transportation

MODIVCARE, a renowned healthcare services company, has proudly recognized Payson Priola as the Maine Driver of the Year. This prestigious honor reflects Priola's commitment to providing essential transportation services for those facing barriers to healthcare access.

The Role of Non-Emergency Transportation

Payson Priola serves as a non-emergency transportation (NET) driver, a crucial role responsible for ferrying Maine Medicaid members to their medical appointments. The importance of this service cannot be overstated, as countless individuals depend on reliable transportation to receive necessary healthcare.

A Dedicated Team Member

Payson began her journey with Modivcare in 2022, and since then, she has become a vital asset, operating primarily in Androscoggin, Franklin, and Oxford Counties. Her consistency and positive attitude have earned her respect and frequent requests from members who appreciate her service.

Recognizing Exceptional Contributions

Her recognition as Driver of the Year underscores Priola's exceptional work ethic and engagement in her role. Modivcare's Fleet Manager, Susan Taylor, stated, "Payson is the definition of a star employee. She is someone we can count on when we need it most. She doesn’t hesitate to take on additional responsibilities, and we are happy that she is a part of our team." This sentiment truly encapsulates the company's appreciation for her contributions.

Priola expresses gratitude for the acknowledgment, emphasizing the significance of her reliability. “It is important for me to be dependable, not only for Modivcare, but for the members who rely on our transportation to make it to their appointments or medical visits,” she shared. Her commitment highlights the core values of Modivcare and its mission to assist members in their healthcare journeys.

Growth of Modivcare's Network

Since its inception, Modivcare has expanded its non-emergency transportation provider network, increasing from just 10 providers in Maine to over 45 local providers. This expansion includes a commitment to diversity, employing 26 minority-owned and four women-owned small businesses, together providing essential services through more than 400 local drivers.

Commitment to Quality Service

Modivcare stands out in its dedication to providing safe, efficient, and timely transportation. Their performance speaks volumes; they boast an impressive on-time performance rate of over 94%. Additionally, their strategies to mitigate member complaints and vehicle unavailability have maintained these figures below 0.1%, which is commendable in the healthcare industry.

Looking Ahead

As Modivcare continues on its journey, Priola remains committed to serving her community through transportation services. She embodies the spirit of Modivcare, focusing on connecting individuals to vital healthcare services, which ultimately contributes to better health outcomes. The firm's extensive efforts, particularly in the field of non-emergency medical transportation, are crucial in bridging gaps for those in need.

Frequently Asked Questions

What is Modivcare?

Modivcare Inc. is a healthcare services company specializing in non-emergency medical transportation, personal care, and virtual monitoring solutions.

Who was named Driver of the Year?

Payson Priola, a transportation driver for Modivcare in Maine, has earned the title of Driver of the Year due to her exceptional service and dedication.

What does a non-emergency transportation driver do?

A non-emergency transportation driver like Priola provides essential transport for Medicaid members to medical appointments, ensuring access to necessary healthcare services.

How has Modivcare grown in Maine?

Since 2014, Modivcare has expanded its network from 10 to over 45 providers in Maine, emphasizing diversity with many minority and women-owned businesses.

What is Modivcare's commitment to service?

Modivcare consistently strives to provide safe, efficient, and timely transportation services, boasting more than 94% on-time performance and low complaint rates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 38

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 30

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Icon Energy Corp. Welcomes M/V Bravo and Secures Funding

Updated Category News Views 84

Icon Energy Corp. Welcomes M/V Bravo and Secures Financing Icon Energy Corp. (“Icon”) (Nasdaq: ICON) is thrilled to announce the arrival of its latest fleet member, the M/V Bravo, alongside significant financing aimed at facilitating future growth. This advanced Kamsarmax dry bulk carrier represents a key achievement in Icon's operational strategy, paving the way for...

Continue Reading
Kimbell Royalty Partners Delivers Strong Q3 2025 Financials

Updated Category News Views 122

Kimbell Royalty Partners Reports Impressive Third Quarter Financial Results Kimbell Royalty Partners, LP (NYSE: KRP), a prominent entity in the oil and natural gas sector, recently revealed its financial performance for the quarter concluding September 30, 2025. The company demonstrated strong operational results despite a challenging industry backdrop. Production and...

Continue Reading
Nscale and Microsoft Partner to Transform AI Infrastructure

Updated Category News Views 255

Nscale and Microsoft's Groundbreaking Partnership Nscale is embarking on an incredible journey with Microsoft, having signed a substantial contract to deploy nearly 200,000 NVIDIA GB300 GPUs. This collaboration aims to redefine AI infrastructure across Europe and the U.S., marking one of the largest agreements in the field of AI technology. Unveiling the Scope of the...

Continue Reading
Alterity Therapeutics Wraps Up Participant Visits in MSA Trial

Updated Category News Views 242

Alterity Therapeutics Wraps Up Patient Visits in Clinical Trial Alterity Therapeutics, recognized for its dedication to tackling neurodegenerative diseases, has reached a significant milestone by completing participant visits in the ATH434-201 Phase 2 clinical trial focusing on early-stage multiple system atrophy (MSA). This trial, which follows a randomized,...

Continue Reading
Huawei Launches Innovative Solutions for European SMEs' Growth

Updated Category News Views 193

Huawei Empowers European SMEs with Intelligent Solutions Huawei, a global leader in information and communications technology, has made significant strides in assisting small and medium-sized enterprises (SMEs) across Europe to embrace digital transformation. The company recently introduced its latest offerings at a major launch event, focusing on simplifying the path for...

Continue Reading